162 related articles for article (PubMed ID: 16033966)
1. Characterization of liver histopathology in a transgenic mouse model expressing genotype 1a hepatitis C virus core and envelope proteins 1 and 2.
Naas T; Ghorbani M; Alvarez-Maya I; Lapner M; Kothary R; De Repentigny Y; Gomes S; Babiuk L; Giulivi A; Soare C; Azizi A; Diaz-Mitoma F
J Gen Virol; 2005 Aug; 86(Pt 8):2185-2196. PubMed ID: 16033966
[TBL] [Abstract][Full Text] [Related]
2. Hepatitis C virus core protein induces hepatic steatosis in transgenic mice.
Moriya K; Yotsuyanagi H; Shintani Y; Fujie H; Ishibashi K; Matsuura Y; Miyamura T; Koike K
J Gen Virol; 1997 Jul; 78 ( Pt 7)():1527-31. PubMed ID: 9225025
[TBL] [Abstract][Full Text] [Related]
3. Activation-induced cytidine deaminase is dispensable for virus-mediated liver and skin tumor development in mouse models.
Nguyen T; Xu J; Chikuma S; Hiai H; Kinoshita K; Moriya K; Koike K; Marcuzzi GP; Pfister H; Honjo T; Kobayashi M
Int Immunol; 2014 Jul; 26(7):397-406. PubMed ID: 24569264
[TBL] [Abstract][Full Text] [Related]
4. PPARalpha activation is essential for HCV core protein-induced hepatic steatosis and hepatocellular carcinoma in mice.
Tanaka N; Moriya K; Kiyosawa K; Koike K; Gonzalez FJ; Aoyama T
J Clin Invest; 2008 Feb; 118(2):683-94. PubMed ID: 18188449
[TBL] [Abstract][Full Text] [Related]
5. A trans-fatty acid-rich diet promotes liver tumorigenesis in HCV core gene transgenic mice.
Hu X; Wang X; Jia F; Tanaka N; Kimura T; Nakajima T; Sato Y; Moriya K; Koike K; Gonzalez FJ; Nakayama J; Aoyama T
Carcinogenesis; 2020 Apr; 41(2):159-170. PubMed ID: 31300810
[TBL] [Abstract][Full Text] [Related]
6. Steatosis and liver cancer in transgenic mice expressing the structural and nonstructural proteins of hepatitis C virus.
Lerat H; Honda M; Beard MR; Loesch K; Sun J; Yang Y; Okuda M; Gosert R; Xiao SY; Weinman SA; Lemon SM
Gastroenterology; 2002 Feb; 122(2):352-65. PubMed ID: 11832450
[TBL] [Abstract][Full Text] [Related]
7. Possible role of cytotoxic T cells in acute liver injury in hepatitis C virus cDNA transgenic mice mediated by Cre/loxP system.
Wakita T; Katsume A; Kato J; Taya C; Yonekawa H; Kanegae Y; Saito I; Hayashi Y; Koike M; Miyamoto M; Hiasa Y; Kohara M
J Med Virol; 2000 Nov; 62(3):308-17. PubMed ID: 11055240
[TBL] [Abstract][Full Text] [Related]
8. Acute expression of hepatitis C core protein in adult mouse liver: Mitochondrial stress and apoptosis.
Chang ML; Chen JC; Chang MY; Yeh CT; Lin WP; Liang CK; Huang SF; Dang KN; Chiu CT; Lin DY
Scand J Gastroenterol; 2008; 43(6):747-55. PubMed ID: 18569993
[TBL] [Abstract][Full Text] [Related]
9. Transgenic expression of hepatitis C virus structural proteins in the mouse.
Kawamura T; Furusaka A; Koziel MJ; Chung RT; Wang TC; Schmidt EV; Liang TJ
Hepatology; 1997 Apr; 25(4):1014-21. PubMed ID: 9096613
[TBL] [Abstract][Full Text] [Related]
10. Natural killer cells target HCV core proteins during the innate immune response in HCV transgenic mice.
Satoh K; Takahashi H; Matsuda C; Tanaka T; Miyasaka M; Zeniya M; Kohara M
J Med Virol; 2010 Sep; 82(9):1545-53. PubMed ID: 20648608
[TBL] [Abstract][Full Text] [Related]
11. Genetic immunization of wild-type and hepatitis C virus transgenic mice reveals a hierarchy of cellular immune response and tolerance induction against hepatitis C virus structural proteins.
Satoi J; Murata K; Lechmann M; Manickan E; Zhang Z; Wedemeyer H; Rehermann B; Liang TJ
J Virol; 2001 Dec; 75(24):12121-7. PubMed ID: 11711603
[TBL] [Abstract][Full Text] [Related]
12. Transgenic expression of Korean type hepatitis C virus core protein and related mutants in mice.
Wang AG; Moon HB; Lee YH; Yu SL; Kwon HJ; Han YH; Fang W; Lee TH; Jang KL; Kim SK; Yu DY; Lee DS
Exp Mol Med; 2004 Dec; 36(6):588-93. PubMed ID: 15675043
[TBL] [Abstract][Full Text] [Related]
13. Subcellular localization of hepatitis C virus structural proteins in the liver of transgenic mice.
Moriya K; Fujie H; Yotsuyanagi H; Shintani Y; Tsutsumi T; Matsuura Y; Miyamura T; Kimura S; Koike K
Jpn J Med Sci Biol; 1997; 50(4-5):169-77. PubMed ID: 9556757
[TBL] [Abstract][Full Text] [Related]
14. Hepatocarcinogenesis in hepatitis C: HCV shrewdly exacerbates oxidative stress by modulating both production and scavenging of reactive oxygen species.
Fujinaga H; Tsutsumi T; Yotsuyanagi H; Moriya K; Koike K
Oncology; 2011; 81 Suppl 1():11-7. PubMed ID: 22212930
[TBL] [Abstract][Full Text] [Related]
15. Hepatitis C virus core and E2 protein expression in transgenic mice.
Pasquinelli C; Shoenberger JM; Chung J; Chang KM; Guidotti LG; Selby M; Berger K; Lesniewski R; Houghton M; Chisari FV
Hepatology; 1997 Mar; 25(3):719-27. PubMed ID: 9049225
[TBL] [Abstract][Full Text] [Related]
16. [Core protein of hepatitis C virus expressed in transgenic mice is associated with the expression of Fas molecule].
Tan W; Lang Z; Cong Y; Chen G; Miao J; Zhan M
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 1997 Sep; 11(3):205-7. PubMed ID: 15617329
[TBL] [Abstract][Full Text] [Related]
17. The core protein of hepatitis C virus induces hepatocellular carcinoma in transgenic mice.
Moriya K; Fujie H; Shintani Y; Yotsuyanagi H; Tsutsumi T; Ishibashi K; Matsuura Y; Kimura S; Miyamura T; Koike K
Nat Med; 1998 Sep; 4(9):1065-7. PubMed ID: 9734402
[TBL] [Abstract][Full Text] [Related]
18. Hepatic iron overload induces hepatocellular carcinoma in transgenic mice expressing the hepatitis C virus polyprotein.
Furutani T; Hino K; Okuda M; Gondo T; Nishina S; Kitase A; Korenaga M; Xiao SY; Weinman SA; Lemon SM; Sakaida I; Okita K
Gastroenterology; 2006 Jun; 130(7):2087-98. PubMed ID: 16762631
[TBL] [Abstract][Full Text] [Related]
19. Hepatitis C virus structural proteins induce liver cell injury in transgenic mice.
Honda A; Arai Y; Hirota N; Sato T; Ikegaki J; Koizumi T; Hatano M; Kohara M; Moriyama T; Imawari M; Shimotohno K; Tokuhisa T
J Med Virol; 1999 Nov; 59(3):281-9. PubMed ID: 10502257
[TBL] [Abstract][Full Text] [Related]
20. A protein coevolution method uncovers critical features of the Hepatitis C Virus fusion mechanism.
Douam F; Fusil F; Enguehard M; Dib L; Nadalin F; Schwaller L; Hrebikova G; Mancip J; Mailly L; Montserret R; Ding Q; Maisse C; Carlot E; Xu K; Verhoeyen E; Baumert TF; Ploss A; Carbone A; Cosset FL; Lavillette D
PLoS Pathog; 2018 Mar; 14(3):e1006908. PubMed ID: 29505618
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
